Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS
Goodrich Katherine sold 2,954 Tarsus Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Goodrich Katherine (Director) sold 2,954 Tarsus Pharmaceuticals, Inc. shares at US$62.08 for US$183K under a trading plan, leaving 2,233 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 2,954 shares
- Price
- US$62.08
- Value
- US$183K
- Holding after
- 2,233 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Sale | 2,954 | US$62.08 | 2,233 | Direct |
Source
Related
- Tarsus Pharmaceuticals, Inc.
- Goodrich Katherine
- Tarsus Pharmaceuticals, Inc. shareholders
- Form 4 · Goodrich Katherine · Jun 16, 2026
- Form 4 · Pyott David E I · Sep 17, 2026
- Form 4 · Yarno Wendy L · Sep 17, 2026
- Form 4 · Link William J Phd · Sep 17, 2026
- Form 4 · Azamian Bobak R. · Sep 9, 2026
- Form 4 · Lin Elizabeth Yeu · Sep 9, 2026